Fluticasone Propionate, Azithromycin, and Montelukast Sodium in Treating Patients With Bronchiolitis Obliterans Who Previously Underwent Stem Cell Transplant

Trial Profile

Fluticasone Propionate, Azithromycin, and Montelukast Sodium in Treating Patients With Bronchiolitis Obliterans Who Previously Underwent Stem Cell Transplant

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Aug 2016

At a glance

  • Drugs Azithromycin (Primary) ; Fluticasone propionate (Primary) ; Montelukast (Primary) ; Prednisone
  • Indications Bacterial infections; Bronchiolitis obliterans
  • Focus Therapeutic Use
  • Acronyms FAM for BOS
  • Most Recent Events

    • 22 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 04 Jun 2013 Planned End Date changed from 1 May 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
    • 02 Apr 2012 Planned number of patients changed from 40 to 42 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top